Convalescent Plasma as a Possible Treatment for COVID-19

NCT04442191 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Illinois at Chicago